Javascript must be enabled to continue!
115-OR: Adipose m6A Reader YTHDF2 Regulates White Adipose Tissue Growth and Metabolism
View through CrossRef
Introduction & Objective: White adipose tissue (WAT) releases free fatty acids (FFAs) via lipolysis to meet metabolic demand in a negative energy state. Excessive WAT growth imposes risk for type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD), but mechanism for aberrant WAT growth is poorly understood. We previously reported that adipose METTL14, a m6A writer installing m6A methylation on RNA, promotes obesity by suppressing lipolysis. The objective of this work is to identify m6A readers mediating METTL14’s action.
Methods: Adipocyte-specific Ythdf2 knockout mice (Ythdf2Δfat) were generated by crossing Ythdf2f/f with Adipoq-Cre mice and fed high fat diet (HFD) for 12 weeks. Lipolysis assays were performed in mice and in WAT explants. RNA immunoprecipitation was used to assess m6A levels and YTHDF2-binding to RNA.
Results: We found that Ythdf2Δfat mice, both males and females, were resistant to HFD-induced obesity. Fat content was significantly lower in Ythdf2Δfat than in Ythdf2f/f littermates. Ablation of adipose Ythdf2 mitigated insulin resistance and MASLD. β-agonist treatment increased plasma FFAs to a higher level in Ythdf2Δfat than in Ythdf2f/f mice. β-agonists also stimulated lipolysis to a higher level in Ythdf2Δfat WAT ex vivo. Adipose triglyceride lipase (ATGL) and CGI-58 (ATGL cofactor) levels were markedly higher in Ythdf2Δfat than in Ythdf2f/f WAT. YTHDF2 bound to Atgl and Cgi-58 mRNAs, and ablation of METTL14 suppressed YTHDF2 interactions with these transcripts. These results suggest that YTHDF2 binds to m6A-marked transcripts to inhibit ATGL and CGI-58 syntheses, thereby suppressing lipolysis.
Conclusion: Our results unveil YTHDF2-based epitranscriptomic reprogramming that governs lipolysis and WAT growth.
Disclosure
R. Zhou: None. L. Rui: None. Q. Kang: None.
Funding
National Institutes of Health (R01DK130111)
Title: 115-OR: Adipose m6A Reader YTHDF2 Regulates White Adipose Tissue Growth and Metabolism
Description:
Introduction & Objective: White adipose tissue (WAT) releases free fatty acids (FFAs) via lipolysis to meet metabolic demand in a negative energy state.
Excessive WAT growth imposes risk for type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD), but mechanism for aberrant WAT growth is poorly understood.
We previously reported that adipose METTL14, a m6A writer installing m6A methylation on RNA, promotes obesity by suppressing lipolysis.
The objective of this work is to identify m6A readers mediating METTL14’s action.
Methods: Adipocyte-specific Ythdf2 knockout mice (Ythdf2Δfat) were generated by crossing Ythdf2f/f with Adipoq-Cre mice and fed high fat diet (HFD) for 12 weeks.
Lipolysis assays were performed in mice and in WAT explants.
RNA immunoprecipitation was used to assess m6A levels and YTHDF2-binding to RNA.
Results: We found that Ythdf2Δfat mice, both males and females, were resistant to HFD-induced obesity.
Fat content was significantly lower in Ythdf2Δfat than in Ythdf2f/f littermates.
Ablation of adipose Ythdf2 mitigated insulin resistance and MASLD.
β-agonist treatment increased plasma FFAs to a higher level in Ythdf2Δfat than in Ythdf2f/f mice.
β-agonists also stimulated lipolysis to a higher level in Ythdf2Δfat WAT ex vivo.
Adipose triglyceride lipase (ATGL) and CGI-58 (ATGL cofactor) levels were markedly higher in Ythdf2Δfat than in Ythdf2f/f WAT.
YTHDF2 bound to Atgl and Cgi-58 mRNAs, and ablation of METTL14 suppressed YTHDF2 interactions with these transcripts.
These results suggest that YTHDF2 binds to m6A-marked transcripts to inhibit ATGL and CGI-58 syntheses, thereby suppressing lipolysis.
Conclusion: Our results unveil YTHDF2-based epitranscriptomic reprogramming that governs lipolysis and WAT growth.
Disclosure
R.
Zhou: None.
L.
Rui: None.
Q.
Kang: None.
Funding
National Institutes of Health (R01DK130111).
Related Results
Prognostic value of comprehensive typing based on m6A and gene cluster
Prognostic value of comprehensive typing based on m6A and gene cluster
Abstract
Background
Triple-negative breast cancer (TNBC) is resistant to targeted therapy with HER2 monoclonal antibodies and endocrine therapy because it lacks the estrog...
N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
Background: N6-methyladenosine (m6A) modification is a part of epigenetic research that has gained increasing attention in recent years. m6A modification is widely involved in many...
Pan-Cancer Analysis Identifies YTHDF2 as an Immunological and Prognostic Biomarker
Pan-Cancer Analysis Identifies YTHDF2 as an Immunological and Prognostic Biomarker
Abstract
Background
N6-methyladenosine (m6A) modification is a dynamic and reversible post-transcriptional RNA modification prevalent in eukaryotic cells. As a member of m...
N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS)
N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS)
Abstract
Background
Polycystic ovary syndrome (PCOS) is a multisystem-related disease whose pathophysiology is still unclear. Several regulators of ...
P1621m6A RNA-methylation in the progression of heart failure
P1621m6A RNA-methylation in the progression of heart failure
Abstract
Introduction
N6-Methyladenosine (m6A) is the most abundant modification of RNA and was found to be a dynamic and revers...
YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFβ1-SMAD2/3 Pathway
YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFβ1-SMAD2/3 Pathway
ObjectiveYTH domain family 2 (YTHDF2) is an important N6-methyladenosine (m6A) reader, but its role in lung adenocarcinoma remains elusive. This study assessed its function in lung...
N6-Methyladenosine RNA Modification Regulates the Differential Muscle Development in Large White and Ningxiang Pigs
N6-Methyladenosine RNA Modification Regulates the Differential Muscle Development in Large White and Ningxiang Pigs
N6-methyladenosine (m6A) is the most common modification in eukaryotic RNAs. Growing research indicates that m6A methylation is crucial for a multitude of biological processes. How...
Deep learning modeling m6A deposition reveals the importance of downstream cis-element sequences
Deep learning modeling m6A deposition reveals the importance of downstream cis-element sequences
AbstractThe N6-methyladenosine (m6A) modification is deposited to nascent transcripts on chromatin, but its site-specificity mechanism is mostly unknown. Here we model the m6A depo...

